# FDA Inspection 1105852 - GraftSource, LLC - September 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/graftsource-llc/6ce3a493-6d33-4dbd-849b-d0523b26ca38
Source feed: FDA_Inspections

> FDA Inspection 1105852 for GraftSource, LLC on September 19, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105852
- Company Name: GraftSource, LLC
- Inspection Date: 2019-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279228 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/graftsource-llc/15120f97-6a46-4cd2-b666-b5e2ab313357)
- [FDA Inspection 1279228 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/graftsource-llc/d5a6c52f-4d56-4982-8e4f-e511d0f3aaef)
- [FDA Inspection 1035434 - 2017-12-05](https://www.keypedia.com/records/fda_inspections/graftsource-llc/fd275aa8-3402-4b0d-9bd0-50c32b90c458)
- [FDA Inspection 865744 - 2014-02-06](https://www.keypedia.com/records/fda_inspections/graftsource-llc/30762c5b-ddba-4576-a392-980b4cb82717)
- [FDA Inspection 762433 - 2012-01-11](https://www.keypedia.com/records/fda_inspections/graftsource-llc/62b500bc-9412-4898-81b1-7d5090a4bcd5)

Company: https://www.keypedia.com/companies/graftsource-llc/f4ba21be-1d0a-4ddf-b02b-a04ab713dead

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d